Impel Neuropharma

$8.33 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Impel Neuropharma

Impel Neuropharma, Inc. operates as a bio-pharmaceutical company. The Company focuses on developing transformative therapies that unlock the full potential of therapeutic molecules for people living with CNS disorders with high unmet medical needs. Impel Neuropharma serves customers worldwide.

Stock Analysis

last close $9.24
1-mo return -13.6%
3-mo return -51.3%
avg daily vol. 223.02T
52-week high 34.75
52-week low 6.9
market cap. $221M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 80.1%
baraka

Subscribe now for daily local and international financial news

Subscribe